Lupus Research Alliance Funds Study to Understand Connection between the Common Epstein-Barr Virus and Lupus
A study funded partly by the Lupus Research Alliance reveals insights into how a common viral infection may cause lupus...
Data at ACR 2022 Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population
Data at ACR 2022 Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population
NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and clinical researchaffiliate Lupus Therapeutics will present data at ACR Convergence 2022 showing that the pilot peer education program Patient Advocates for Lupus Studies (PALS), increased knowledge, perception, and intentions among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials. These study results (Abstract #2245) offer promise particularly for groups often underrepresented in clinical studies, including those of Black ancestry.
The full press release is available on the Lupus Therapeutics website.
